EX-99.1 2 tm2415124d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

AGREEMENT

JOINT FILING OF SCHEDULE 13D

 

The undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of Atara Biotherapeutics, Inc., and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

 

Date: May 22, 2024 ADIUMENTUM CAPITAL FUND I LP
   
  By: Adiumentum Capital Fund I GP LLC, its general partner

 

  By: /s/ Gregory A. Ciongoli
    Name: Gregory A. Ciongoli
    Title: Managing Member

 

Date: May 22, 2024 ADIUMENTUM CAPITAL FUND I GP LLC
   
  By: /s/ Gregory A. Ciongoli
    Name: Gregory A. Ciongoli
    Title: Managing Member
   
Date: May 22, 2024 GREGORY A. CIONGOLI
   
  By: /s/ Gregory A. Ciongoli    
    Gregory A. Ciongoli